Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Procter & Gamble Co
EIR
•Procter & Gamble Co•April 6, 2017

Procter & Gamble Co – FDA EIR, Apr 6, 2017

Record Details

An FDA inspection was conducted at Procter & Gamble Co.'s corporate headquarters and research and development center in Cincinnati, OH, on April 6, 2017. The inspection, performed under CP7356.002 (Drug Process Inspections), focused on the firm's handling of two consumer complaint reports. No objectionable issues were identified, and no FDA-483 was issued during this limited, directed inspection.

The first complaint, MSB report 2017-01188, involved Metamucil Therapy for Regularity, where a consumer reported possible foreign material resembling animal bones and fat. Procter & Gamble's investigation, which included retrieving and testing the product sample, reviewing batch records, and assessing manufacturing processes, concluded that the material was likely wet, clumped Metamucil powder. The firm found no evidence of foreign object contamination and confirmed robust manufacturing controls.

The second complaint, MSB report 2017-01806, concerned Old Spice Wild Collection Bearglove deodorant, with a consumer reporting a severe burning and itching rash. The company investigated this adverse event, examining manufacturing, packaging, and analytical records for the specific lot. While this lot had only one such complaint, Procter & Gamble acknowledged receiving 30 similar reports for this product type over the past year, which they actively track using a statistical signal detection system. Analytical testing of retain samples confirmed the active ingredient content was within specifications.

Given that no significant issues were found and the firm adequately investigated both complaints, no specific actions were required by the FDA from this inspection.

Company
Procter & Gamble Co
Inspection date
April 6, 2017
Product type
drugs
Office
Cincinnati District Office
Person
  • Michael P. Sheehan (General Manager)
View Company Profile

ID · 31ae8859-bc82-42f2-9f38-65df6bab22bb

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Procter & Gamble Co
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.